Waystar Sold the Future; the P&L Has to Wait for It
Record bookings and AI-heavy demand collided with a 6% Q4 growth guide — the bill for performance-based pricing and longer implementations came due.
WAY · Earnings Call · 2026-11-02
The beat was clean; the guide was the story
Waystar's third quarter was another strong operating print. Revenue rose 21% to $326 million, organic growth was 10%, adjusted EBITDA rose 24% to $139 million at a 43% margin, and unlevered free cash flow was $115 million. The company also signed “the largest new client win in Waystar's history... approximately $7 billion in annual net patient revenue” — Matthew Hawkins, Chief Executive Officer · 2026-11-02, a major East Coast health system replacing more than 20 vendors. Year-to-date bookings grew 25%. On the surface, commercial momentum has rarely looked better.
Then came the fourth-quarter guide. Full-year revenue is now $1.277 billion to $1.287 billion, implying Q4 revenue of roughly $323 million and growth of about 6%. That is a sharp deceleration from the 21% just reported. Management attributed it to three factors: the accelerated shift from printed to digital patient statements, an Iodine mix shift toward Prebill Anomaly Detection where performance-based revenue recognition takes longer, and the lapping of three large client implementations that ramped unusually quickly a year ago. “This implies fourth quarter revenue of approximately $323 million and revenue growth of approximately 6%.” — Alpana Wegner, Chief Financial Officer · 2026-11-02 The market has already re-rated the stock — up 41.4% in the last 90 trading days into this print, though still 37.9% below its February 2025 peak — so the burden is now on proving that this is timing, not a crack in the growth model.
Without these 3 factors, our normalized fourth quarter growth rate would be approximately 10%.
Prebill is the hinge
The most important change is not demand. It is the pricing model. Waystar deliberately moved its Prebill Anomaly Detection offering away from a subscription construct and toward an outcome based model, charging on the revenue dollars or claim changes the AI identifies. That is a strategically sound way to price to value, but it elongates the path from booking to recognized revenue because performance must be demonstrated before dollars flow. Matt Hawkins was explicit: “we made the decision to price our Prebill Anomaly Detection solution on that basis because we see some competing offerings in the market that are also priced on an outcomes or a performance basis” — Matthew Hawkins, Chief Executive Officer · 2026-11-02.
This was not a total surprise. On the February 2026 call, Hawkins had already signaled the direction: “We are absolutely willing to explore some performance-based pricing opportunity in this space.” — Matthew J. Hawkins, Chief Executive Officer · 2026-02-17 What changed is that the option has become the P&L. Iodine revenue is now expected lower in fiscal 2026 than previously anticipated, while management insists the 2027 accretion thesis is unchanged. Investors are being asked to separate commercial demand from accounting timing. The bookings say demand is real; the Q4 guide says the revenue clock has slowed.
The backlog disclosure is the tell
Waystar also gave investors new metrics that amount to a disclosure upgrade: 1,488 clients generating more than $100,000 of trailing 12-month revenue, up 14% year over year; an average of about five product modules within that large-client cohort; bookings from opportunities greater than $100,000 up more than 30% year to date; and implementation backlog up more than 50% year over year, with a mid-30% two-year CAGR. That is exactly the visibility investors have been demanding. But it also confirms the tension: the company can see contracted future revenue, yet conversion is taking longer.
On the prior July 2026 call, Hawkins acknowledged that large wins were already stretching: “some of these are taking slightly longer to implement” — Matthew Hawkins, Chief Executive Officer · 2026-07-29. This quarter, CFO Alpana Wegner put a cleaner range on it: “Larger, broader platform implementations naturally have longer revenue conversion times, which can extend to 12 to 18 months.” — Alpana Wegner, Chief Financial Officer · 2026-11-02 The upper bound is not new, but the lower bound has moved up. That matters because Waystar's pitch is increasingly a platform replacement story — more modules, more workflows, more vendors displaced. Larger deals are better for the long term and worse for near-term revenue optics.
What 2027 has to prove
The print to digital shift is another old theme with a new bite. Waystar has discussed digital patient statements for several quarters; this quarter the mix moved faster than expected, pressuring patient-payment revenue while improving margin economics. Add the lapping of three rapid implementations, and Q4 becomes a cleanup quarter. Management says those comparisons roll off as the year exits, leaving a cleaner 2027 setup. The Iodine cross-sell pipeline — more than $100 million, with Prebill demand strong — is the evidence they point to.
Financially, the company still has room to wait. Revenue reached $320 million in Q2 2026, up 18% year over year, before Q3's $326 million. Net leverage is 2.2x, more than a full turn better than a year ago, with $277 million of cash and short-term investments. Effective net cash was -$1.4 billion in Q2 2026, an improvement from deeper net debt a year earlier. The valuation has also compressed: Price-to-revenue was 3.3x in Q2 2026, down from a 7.0x peak in 2025. That gives some cushion, but not infinite patience.
Waystar's AI story is not the same as the market's data-center capex trade. It is a workflow and pricing story: new SKUs, premium AI modules, and now outcome-based contracts. The company says it is not seeing competitive deterioration — “We're not seeing a change in the competitive environment or our win rates” — Matthew Hawkins, Chief Executive Officer · 2026-11-02 — and the bookings support that. But the next two quarters must show the backlog converting. If it does, Q4's 6% guide becomes the trough before a cleaner 2027. If it does not, the market will stop paying for bookings and start discounting them.